RT @MBLICorp: Check out this enlightening publication citing our Biotinylated MHC Class I Monomers. https://t.co/giSASiYOI2 Product code T…
Check out this enlightening publication citing our Biotinylated MHC Class I Monomers. https://t.co/giSASiYOI2 Product code TB-M505-M https://t.co/gLRVika80b
RT @MBLICorp: Check out this enlightening publication citing our Biotinylated MHC Class I Monomers. https://t.co/gUVSG9TKkq Product code T…
Check out this enlightening publication citing our Biotinylated MHC Class I Monomers. https://t.co/gUVSG9TKkq Product code TB-M505-M/M2 https://t.co/a4z3kn4LfE
Some really nice work by the folks over at @rubius_tx
Zhang et al engineered red blood cells as off-the-shelf allogeneic anti-tumor therapeutic option: https://t.co/SRIn4hkEs1 https://t.co/wXOfu9CV88
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic https://t.co/my6eIpinHB @DrGauravNarula @CTCTC_tmc
Investigators engineered #RedBloodCells into artificial antigen-presenting cells presenting a peptide bound to the major histocompatibility complex I, the costimulatory ligand 4-1BBL, and interleukin-12. @NatureComms: https://t.co/gXuFYShf5s https://t.co/
Rubius Therapeutics (@rubius_tx) researchers engineer red blood cells into artificial antigen-presenting cells, which could be used as an allogeneic immunotherapy for human papilloma virus+ cancers https://t.co/seu042IUSP
RT @NatureComms: Engineered red blood cells as artificial antigen presenting cells for cancer immunotherapy. https://t.co/TZGZXDa8Aj #Cance…
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic https://t.co/0wH9ndXDag https://t.co/c67p7xVFCd
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic https://t.co/4iNe6UyEnh
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic https://t.co/ab4cNbpWTx
RT @NatureComms: Engineered red blood cells as artificial antigen presenting cells for cancer immunotherapy. https://t.co/TZGZXDa8Aj #Cance…
This is an interesting concept. Why not use the well-established oxygen transportation infrastructure to deliver something else.
RT @NatureComms: Engineered red blood cells as artificial antigen presenting cells for cancer immunotherapy. https://t.co/TZGZXDa8Aj #Cance…
@alanlparker
Glóbulos rojos diseñados como un tratamiento antitumoral alogénico disponible en el mercado https://t.co/rwIZM8v623
RT @NatureComms: Engineered red blood cells as artificial antigen presenting cells for cancer immunotherapy. https://t.co/TZGZXDa8Aj #Cance…
RT @NatureComms: Engineered red blood cells as artificial antigen presenting cells for cancer immunotherapy. https://t.co/TZGZXDa8Aj #Cance…
Engineered red blood cells as artificial antigen presenting cells for cancer immunotherapy. https://t.co/TZGZXDa8Aj #CancerResearch @rubius_tx https://t.co/QuHwhRrEod
RT @Aenoreth: Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic https://t.co/pqyZuSbaWy
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic https://t.co/pqyZuSbaWy
RT @celltherapynews: 🔧 A team of researchers has engineered #RedBloodCells as a potential ‘off-the-shelf’ in vivo cellular #immunotherapy f…
RT @celltherapynews: 🔧 A team of researchers has engineered #RedBloodCells as a potential ‘off-the-shelf’ in vivo cellular #immunotherapy f…
🔧 A team of researchers has engineered #RedBloodCells as a potential ‘off-the-shelf’ in vivo cellular #immunotherapy for treating human papilloma virus+ cancers. Find it in @NatureComms https://t.co/6fgh913IQH https://t.co/ch4yGPu5IO
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic: https://t.co/GGajICwGPB